Amyotrophic lateral sclerosis multiprotein biomarkers in peripheral blood mononuclear cells

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Nardo, Giovanni ^a,b   Pozzi, Silvia ^a,b   Pignataro, Mauro ^a,b   Lauranzano, Eliana ^a,b   Spano, Giorgia ^a,b   Garbelli, Silvia ^c   Mantovani, Stefania ^c   Marinou, Kalliopi ^c   Papetti, Laura ^c   Monteforte, Marta ^b   Torri, Valter ^b   Paris, Luca ^b   Bazzoni, Gianfranco ^b   Lunetta, Christian ^d   Corbo, Massimo ^d   Mora, Gabriele ^c   Bendotti, Caterina ^b   Bonetto, Valentina ^a,b  

^a DULBECCO TELETHON INSTITUTE   (Italy)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^c IRCCS   (Italy)

^d OSPEDALE NIGUARDA CA GRANDA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; CALRETICULIN; CHLORIDE INTRACELLULAR CHANNEL PROTEIN 1; COPPER ZINC SUPEROXIDE DISMUTASE; CYCLOPHILIN A; ENDOPLASMIC RETICULUM PROTEIN ERP57; FAR UPSTREAM ELEMENT BINDING PROTEIN 1; GLUTATHIONE S TRANSFERASE OMEGA 1; HEAT SHOCK COGNATE PROTEIN 70; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A2 B1; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 4; MEMBRANE PROTEIN; PEPTIDYLPROLYL CIS TRANS ISOMERASE A; PEROXIREDOXIN 2; PROTEASOME ACTIVATOR COMPLEX SUBUNIT 1; PROTEIN DISULFIDE ISOMERASE; PROTEIN DISULFIDE ISOMERASE A3; RILUZOLE; TAR DNA BINDING PROTEIN; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; PROTEOME;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOSKELETON; DNA BINDING; ENDOPLASMIC RETICULUM STRESS; ENERGY METABOLISM; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; IMMUNOASSAY; IMMUNOREACTIVITY; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; NITRATIVE STRESS; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATION REDUCTION STATE; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN FOLDING; PROTEOMICS; RAT; RNA BINDING; RNA PROCESSING; SENSITIVITY AND SPECIFICITY; VALIDATION PROCESS; ANIMAL; DISEASE COURSE; METABOLISM; MONONUCLEAR CELL; REPRODUCIBILITY; TRANSLATIONAL RESEARCH;

ANIMALIA; RATTUS;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; BIOLOGICAL MARKERS; DISEASE PROGRESSION; HUMANS; LEUKOCYTES, MONONUCLEAR; PROTEOME; PROTEOMICS; RATS; REPRODUCIBILITY OF RESULTS; TRANSLATIONAL MEDICAL RESEARCH;

EID: 80053615914     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0025545     Document Type: Article

References (56)

1. Turner MR, Kiernan MC, Leigh PN, Talbot K, (2009) Biomarkers in amyotrophic lateral sclerosis. Lancet Neurol 8: 94-109.
2. Aguirre T, Van Den Bosch L, Goetschalckx K, Tilkin P, Mathijs G, et al. (1998) Increased sensitivity of fibroblasts from amyotrophic lateral sclerosis patients to oxidative stress. Ann Neurol 43: 452-457.
3. Clement AM, Nguyen MD, Roberts EA, Garcia ML, Boillee S, et al. (2003) Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science 302: 113-117.
4. Curti D, Malaspina A, Facchetti G, Camana C, Mazzini L, et al. (1996) Amyotrophic lateral sclerosis: oxidative energy metabolism and calcium homeostasis in peripheral blood lymphocytes. Neurology 47: 1060-1064.
5. Dobrowolny G, Aucello M, Rizzuto E, Beccafico S, Mammucari C, et al. (2008) Skeletal muscle is a primary target of SOD1G93A-mediated toxicity. Cell Metab 8: 425-436.
6. Ono S, (2000) The skin in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 1: 191-199.
7. Wong M, Martin LJ, (2010) Skeletal Muscle-Restricted Expression of Human SOD1 Causes Motor Neuron Degeneration in Transgenic Mice. Hum Mol Genet 19: 2284-2302.
8. Beers DR, Henkel JS, Xiao Q, Zhao W, Wang J, et al. (2006) Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A 103: 16021-16026.
9. Cova E, Cereda C, Galli A, Curti D, Finotti C, et al. (2006) Modified expression of Bcl-2 and SOD1 proteins in lymphocytes from sporadic ALS patients. Neurosci Lett 399: 186-190.
10. Mantovani S, Garbelli S, Pasini A, Alimonti D, Perotti C, et al. (2009) Immune system alterations in sporadic amyotrophic lateral sclerosis patients suggest an ongoing neuroinflammatory process. J Neuroimmunol 210: 73-79.
11. Nardo G, Pozzi S, Mantovani S, Garbelli S, Marinou K, et al. (2009) Nitroproteomics of peripheral blood mononuclear cells from patients and a rat model of ALS. Antioxid Redox Signal 11: 1559-1567.
12. Poulopoulou C, Davaki P, Koliaraki V, Kolovou D, Markakis I, et al. (2005) Reduced expression of metabotropic glutamate receptor 2mRNA in T cells of ALS patients. Ann Neurol 58: 946-949.
13. Ganesalingam J, An J, Shaw CE, Shaw G, Lacomis D, et al. (2010) Combination of neurofilament heavy chain and complement C3 as CSF biomarkers for ALS. J Neurochem.
14. Mitchell RM, Freeman WM, Randazzo WT, Stephens HE, Beard JL, et al. (2009) A CSF biomarker panel for identification of patients with amyotrophic lateral sclerosis. Neurology 72: 14-19.
15. Pasinetti GM, Ungar LH, Lange DJ, Yemul S, Deng H, et al. (2006) Identification of potential CSF biomarkers in ALS. Neurology 66: 1218-1222.
16. Mitchell RM, Simmons Z, Beard JL, Stephens HE, Connor JR, (2010) Plasma biomarkers associated with ALS and their relationship to iron homeostasis. Muscle Nerve 42: 95-103.
17. Hu Y, Malone JP, Fagan AM, Townsend RR, Holtzman DM, (2005) Comparative proteomic analysis of intra- and interindividual variation in human cerebrospinal fluid. Mol Cell Proteomics 4: 2000-2009.
18. Zhang J, (2007) Proteomics of human cerebrospinal fluid- the good, the bad, and the ugly. Proteomics Clin Appl 1: 805-819.
19. Atkin JD, Farg MA, Turner BJ, Tomas D, Lysaght JA, et al. (2006) Induction of the unfolded protein response in familial amyotrophic lateral sclerosis and association of protein-disulfide isomerase with superoxide dismutase 1. J Biol Chem 281: 30152-30165.
20. Atkin JD, Farg MA, Walker AK, McLean C, Tomas D, et al. (2008) Endoplasmic reticulum stress and induction of the unfolded protein response in human sporadic amyotrophic lateral sclerosis. Neurobiol Dis 30: 400-407.
21. Kato S, Kato M, Abe Y, Matsumura T, Nishino T, et al. (2005) Redox system expression in the motor neurons in amyotrophic lateral sclerosis (ALS): immunohistochemical studies on sporadic ALS, superoxide dismutase 1 (SOD1)-mutated familial ALS, and SOD1-mutated ALS animal models. Acta Neuropathol 110: 101-112.
22. Massignan T, Casoni F, Basso M, Stefanazzi P, Biasini E, et al. (2007) Proteomic analysis of spinal cord of presymptomatic amyotrophic lateral sclerosis G93A SOD1 mouse. Biochem Biophys Res Commun 353: 719-725.
23. van de Giessen E, Fogh I, Gopinath S, Smith B, Hu X, et al. (2008) Association study on glutathione S-transferase omega 1 and 2 and familial ALS. Amyotroph Lateral Scler 9: 81-84.
24. Watanabe M, Dykes-Hoberg M, Culotta VC, Price DL, Wong PC, et al. (2001) Histological evidence of protein aggregation in mutant SOD1 transgenic mice and in amyotrophic lateral sclerosis neural tissues. Neurobiol Dis 8: 933-941.
25. Casoni F, Basso M, Massignan T, Gianazza E, Cheroni C, et al. (2005) Protein nitration in a mouse model of familial amyotrophic lateral sclerosis: possible multifunctional role in the pathogenesis. J Biol Chem 280: 16295-16304.
26. Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, et al. (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314: 130-133.
27. De Marco G, Lupino E, Calvo A, Moglia C, Buccinna B, et al. (2011) Cytoplasmic accumulation of TDP-43 in circulating lymphomonocytes of ALS patients with and without TARDBP mutations. Acta Neuropathol 121: 611-622.
28. Achiron A, Gurevich M, (2006) Peripheral blood gene expression signature mirrors central nervous system disease: the model of multiple sclerosis. Autoimmun Rev 5: 517-522.
29. Borovecki F, Lovrecic L, Zhou J, Jeong H, Then F, et al. (2005) Genome-wide expression profiling of human blood reveals biomarkers for Huntington's disease. Proc Natl Acad Sci U S A 102: 11023-11028.
30. Maes OC, Xu S, Yu B, Chertkow HM, Wang E, et al. (2007) Transcriptional profiling of Alzheimer blood mononuclear cells by microarray. Neurobiol Aging 28: 1795-1809.
31. Davenport RJ, Swingler RJ, Chancellor AM, Warlow CP, (1996) Avoiding false positive diagnoses of motor neuron disease: lessons from the Scottish Motor Neuron Disease Register. J Neurol Neurosurg Psychiatry 60: 147-151.
32. Traynor BJ, Codd MB, Corr B, Forde C, Frost E, et al. (2000) Amyotrophic lateral sclerosis mimic syndromes: a population-based study. Arch Neurol 57: 109-113.
33. Kraemer M, Buerger M, Berlit P, (2010) Diagnostic problems and delay of diagnosis in amyotrophic lateral sclerosis. Clin Neurol Neurosurg 112: 103-105.
34. Srinivasan J, Scala S, Jones HR, Saleh F, Russell JA, (2006) Inappropriate surgeries resulting from misdiagnosis of early amyotrophic lateral sclerosis. Muscle Nerve 34: 359-360.
35. Staschke KA, Dong S, Saha J, Zhao J, Brooks NA, et al. (2009) IRAK4 kinase activity is required for Th17 differentiation and Th17-mediated disease. J Immunol 183: 568-577.
36. Sharp FR, Xu H, Lit L, Walker W, Apperson M, et al. (2006) The future of genomic profiling of neurological diseases using blood. Arch Neurol 63: 1529-1536.
37. Tang Y, Lu A, Aronow BJ, Sharp FR, (2001) Blood genomic responses differ after stroke, seizures, hypoglycemia, and hypoxia: blood genomic fingerprints of disease. Ann Neurol 50: 699-707.
38. Gladkevich A, Kauffman HF, Korf J, (2004) Lymphocytes as a neural probe: potential for studying psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry 28: 559-576.
39. Basso M, Samengo G, Nardo G, Massignan T, D'Alessandro G, et al. (2009) Characterization of detergent-insoluble proteins in ALS indicates a causal link between nitrative stress and aggregation in pathogenesis. PLoS ONE 4: e8130.
40. Kim I, Xu W, Reed JC, (2008) Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities. Nat Rev Drug Discov 7: 1013-1030.
41. Beckman JS, (1996) Oxidative damage and tyrosine nitration from peroxynitrite. Chem Res Toxicol 9: 836-844.
42. Board PG, Coggan M, Chelvanayagam G, Easteal S, Jermiin LS, et al. (2000) Identification, characterization, and crystal structure of the Omega class glutathione transferases. J Biol Chem 275: 24798-24806.
43. Ghezzi P, Casagrande S, Massignan T, Basso M, Bellacchio E, et al. (2006) Redox regulation of cyclophilin A by glutathionylation. Proteomics 6: 817-825.
44. Milton RH, Abeti R, Averaimo S, DeBiasi S, Vitellaro L, et al. (2008) CLIC1 function is required for beta-amyloid-induced generation of reactive oxygen species by microglia. J Neurosci 28: 11488-11499.
45. Wood ZA, Schroder E, Robin Harris J, Poole LB, (2003) Structure, mechanism and regulation of peroxiredoxins. Trends Biochem Sci 28: 32-40.
46. Beal MF, Ferrante RJ, Browne SE, Matthews RT, Kowall NW, et al. (1997) Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis. Ann Neurol 42: 644-654.
47. Ferrante RJ, Shinobu LA, Schulz JB, Matthews RT, Thomas CE, et al. (1997) Increased 3-nitrotyrosine and oxidative damage in mice with a human copper/zinc superoxide dismutase mutation. Ann Neurol 42: 326-334.
48. Barber SC, Mead RJ, Shaw PJ, (2006) Oxidative stress in ALS: a mechanism of neurodegeneration and a therapeutic target. Biochim Biophys Acta 1762: 1051-1067.
49. Ilieva EV, Ayala V, Jove M, Dalfo E, Cacabelos D, et al. (2007) Oxidative and endoplasmic reticulum stress interplay in sporadic amyotrophic lateral sclerosis. Brain 130: 3111-3123.
50. Krecic AM, Swanson MS, (1999) hnRNP complexes: composition, structure, and function. Curr Opin Cell Biol 11: 363-371.
51. Buratti E, Brindisi A, Giombi M, Tisminetzky S, Ayala YM, et al. (2005) TDP-43 binds heterogeneous nuclear ribonucleoprotein A/B through its C-terminal tail: an important region for the inhibition of cystic fibrosis transmembrane conductance regulator exon 9 splicing. J Biol Chem 280: 37572-37584.
52. Lemmens R, Moore MJ, Al-Chalabi A, Brown RH Jr, Robberecht W, (2010) RNA metabolism and the pathogenesis of motor neuron diseases. Trends Neurosci 33: 249-258.
53. Appel SH, Beers DR, Henkel JS, (2010) T cell-microglial dialogue in Parkinson's disease and amyotrophic lateral sclerosis: are we listening? Trends Immunol 31: 7-17.
54. Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, et al. (1999) The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci 169: 13-21.
55. Pappin DJ, Hojrup P, Bleasby AJ, (1993) Rapid identification of proteins by peptide-mass fingerprinting. Curr Biol 3: 327-332.
56. Carpi D, Korkalainen M, Airoldi L, Fanelli R, Hakansson H, et al. (2009) Dioxin-sensitive proteins in differentiating osteoblasts: effects on bone formation in vitro. Toxicol Sci 108: 330-343.